News | December 29, 2016

Intarcia Secures Second Close of the Series EE Equity Financing for an Additional $206M; As Part of the Financing and a New Strategic Initiative, Intarcia Now Aims Its Medici Technology Towards Preventing HIV ? The Bill & Melinda Gates Foundation is committing up...

News | December 13, 2016

Dimension Therapeutics Announces FDA Acceptance of Investigational New Drug Application for DTX301 to Treat OTC Deficiency On Track to Initiate Phase 1/2 Global, Multi-Center Clinical Trial by Year End 2016 Most Advanced of Five Inherited Metabolic Disease Programs...

News | December 6, 2016

Arvinas Collaborators Present Data on BET PROTAC Degraders at 2016 ASH Annual Meeting NEW HAVEN, Conn., December 6, 2016 – Arvinas LLC, a private biotechnology company creating a new class of drugs known as PROTACs which function via targeted protein degradation,...

News | December 1, 2016

Deciphera Pharmaceuticals Reports Encouraging Clinical Results with DCC-2618 in Genetically-defined Cancers with Drug Resistant Mutations Waltham, MA | December 1, 2016 Advanced Kinase Inhibitors with Improved Tumor Targeting Offer Potential for Durable Responses in...

News | December 1, 2016

AiCure’s Artificial Intelligence Platform Wins 2016 Scrip Award Using artificial intelligence to optimize patient behavior NEW YORK, Dec. 1, 2016 /PRNewswire/ — AiCure, which uses artificial intelligence (AI) on mobile devices to visually confirm medication ingestion,...
luctus Phasellus mi, diam dictum neque. leo. elit. quis, porta. eget libero.